World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
19229
World Ranking
19980
National Ranking
1039

Rainer Fietkau publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rainer Fietkau sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 610 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rainer Fietkau D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rainer Fietkau sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 71 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rainer Fietkau is affiliated with the University of Erlangen-Nuremberg in Germany and has made significant contributions to the field of medicine with a focus on oncology, radiology, and related disciplines. Their research spans various subfields including oncology, radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, radiation, and surgery.

The scientist's work primarily concentrates on advanced radiotherapy techniques, cancer immunotherapy and biomarkers, radiomics and machine learning applications in medical imaging, medical imaging techniques and applications, glioma diagnosis and treatment, head and neck cancer studies, and brain metastases and treatment.

Rainer Fietkau has published extensively in several prominent venues, with a notable number of contributions in:

  • Strahlentherapie und Onkologie (37 publications)
  • Radiotherapy and Oncology (16 publications)
  • Cancers (15 publications)
  • arXiv (Cornell University) (13 publications)
  • Laryngo-Rhino-Otologie (11 publications)

Frequent co-authors in their research collaborations include Christoph Bert, Florian Putz, Benjamin Frey, Udo S. Gaipl, and Markus Hecht, reflecting a robust network of joint scientific efforts.

Some representative publications highlight the scope and impact of their research contributions:

  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines, 2023, European Urology
  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer, 2021, JAMA Oncology
  • The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma, 2021, European Urology
  • Benchmarking ChatGPT-4 on a radiation oncology in-training exam and Red Journal Gray Zone cases: potentials and challenges for AI-assisted medical education and decision making in radiation oncology, 2023, Frontiers in Oncology
  • DEGRO practical guideline for partial-breast irradiation, 2020, Strahlentherapie und Onkologie

Best Publications

  • Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

    Rolf Sauer;Heinz Becker;Werner Hohenberger;Claus Rödel

  • Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

    Rolf Sauer;Torsten Liersch;Susanne Merkel;Rainer Fietkau

  • Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer

    Claus Rödel;Peter Martus;Thomas Papadoupolos;Laszlo Füzesi

  • ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

    J. Arends;G. Bodoky;F. Bozzetti;K.C. Fearon

  • Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

    Claus Rödel;Claus Rödel;Ullrich Graeven;Rainer Fietkau;Werner Hohenberger

  • 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

    Vratislav Strnad;Oliver J Ott;Guido Hildebrandt;Daniela Kauer-Dorner

  • Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

    Claus Rödel;Torsten Liersch;Heinz Becker;Rainer Fietkau

  • Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

    Nicola Gökbuget;Michael Kneba;Thorsten Raff;Heiko Trautmann

  • Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

    Emmanouil Fokas;Torsten Liersch;Rainer Fietkau;Werner Hohenberger

  • Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

    Emmanouil Fokas;Michael Allgäuer;Bülent Polat;Gunther Klautke

  • Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.

    Henriette Golcher;Thomas B. Brunner;Helmut Witzigmann;Lukas Marti

  • Old and new facts about hyperthermia-induced modulations of the immune system.

    Benjamin Frey;Eva-Maria Weiss;Yvonne Rubner;Roland Wunderlich

  • Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

    Dieter Hoelzer;Jan Walewski;Hartmut Döhner;Andreas Viardot

  • Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96)

    Peter Koch;Andreas Probst;Wolfgang E. Berdel;Normann A. Willich

  • Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.

    R. Sauer;R. Fietkau;C. Wittekind;C. Rödel

  • [German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"]

    M. Moehler;Se-E. Al-Batran;T. Andus;M. Anthuber

  • Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

    Csaba Polgár;Oliver J Ott;Guido Hildebrandt;Daniela Kauer-Dorner

  • The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma.

    Richard Cathomas;Anja Lorch;Harman M. Bruins;Eva M. Compérat

  • [S3-guideline exocrine pancreatic cancer].

    T. Seufferlein;M. Porzner;T. Becker;V. Budach

  • Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.

    Emmanouil Fokas;Emmanouil Fokas;Anke Schlenska-Lange;Bülent Polat;Gunther Klautke

Frequent Co-Authors

Rolf Sauer
Rolf Sauer University of Erlangen-Nuremberg
Benjamin Frey
Benjamin Frey University of Erlangen-Nuremberg
Udo S. Gaipl
Udo S. Gaipl University of Erlangen-Nuremberg
Claus Rödel
Claus Rödel Goethe University Frankfurt
Werner Hohenberger
Werner Hohenberger University of Erlangen-Nuremberg
Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Claus Belka
Claus Belka Ludwig-Maximilians-Universität München
Thomas Brunner
Thomas Brunner University of Konstanz
Peter Martus
Peter Martus University of Tübingen
Franz Rödel
Franz Rödel Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering alternatives or complementary routes to studying Medicine in the USA, exploring online healthcare degrees can offer greater flexibility and a range of career options. Popular pathways include healthcare administration, advanced nursing, and leadership roles.

For those interested in healthcare management, pursuing one of the best mha programs can lead to rewarding administrative positions. Registered nurses seeking career advancement can explore rn to bsn online programs without clinicals, providing a convenient way to earn a bachelor’s degree.

Advanced practice nurses may benefit from dnp online programs that are designed to be completed in less time, helping students achieve a Doctor of Nursing Practice degree efficiently. For those prioritizing affordability, the cheapest dnp program options can minimize financial stress while advancing one’s qualifications.

Each of these study routes can open doors to leadership, innovation, and high-impact roles in healthcare, making them strong choices for those passionate about medicine and patient care.

Best Scientists Citing Rainer Fietkau

Trending Scientists

Recently Published Articles